Company: LNAI
Filing Date: 2025-10-15
Form Type: DEF 14A
Source: 0001731122-25-001378
Chunk: 20

Company: Lunai Bioworks Inc.
Filing Date: 2025-10-15
Form: DEF 14A
Chunk 20
---
 has an active role in managing enterprise risk. The members of the Board participate in our risk oversight assessment
by receiving regular reports from members of senior management on areas of material risk to us, including operational, financial, legal
and regulatory, and strategic and reputational risks. The Compensation Committee is responsible for overseeing the management of risks
relating to our executive compensation plans and arrangements. The Audit Committee oversees management of financial risks as well as our
policies with respect to risk assessment and risk management. The Nominating and Corporate Governance Committee manages risks associated
with the independence of the Board and potential conflicts of interest. Members of the management team report directly to the Board or
the appropriate committee. The directors then use this information to understand, identify, manage, and mitigate risk. Once a committee
has considered the reports from management, the chair of that committee will report on the matter to the full Board at the next meeting
of the Board, or sooner if deemed necessary. This enables the Board and its committees to effectively carry out its risk oversight role.

Communications with the Board of Directors

Stockholders may, at any time,
communicate with any of our directors by mailing a written communication to our principal executive offices, Attention: Chairman of the
Board. The mailing envelope must contain a clear notation indicating that the enclosed letter is a “Stockholder-Board Communication”
or “Stockholder-Director Communication.” All such letters must identify the author as a stockholder, provide evidence of the
sender’s stock ownership and clearly state whether the intended recipients are all members of the Board or a particular director
or directors. The Corporate Secretary will then forward such correspondence, without editing or alteration, to the Board or to the specified
director(s) on or prior to the next scheduled meeting of the Board. The Board will determine the method by which such submissions will
be reviewed and considered. The Board may also request the submitting stockholder to furnish additional information it may reasonably
require or deem necessary to sufficiently review and consider the submission of such stockholder.

Clawback Policy

We have adopted a Clawback Policy
which provides for the recovery of certain incentive compensation in the event of an accounting restatement. Under the Clawback Policy,
if the Company’s financial results are restated, due to the Company’s material noncompliance with any financial reporting
requirements under securities laws, the portion of any amounts of incentive compensation paid to the Company’s current and former
executive officers based on erroneous data will be recouped from those